SciSparc Ltd. Announces $20 Million Standby Equity Purchase

TEL AVIV, Israel, Jan. 24, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical...

Related Keywords

Israel ,United States , ,Scisparc Ltd ,Nasdaq ,Exchange Commission ,Ya Ii Pn Ltd ,Company Or Scisparc ,Yorkville Advisors Global ,Securities Act ,Tourette Syndrome ,Looking Statements ,Annual Report ,Nasdaq Sprc ,Tandbyequitypurchaseagreement ,